Sometimes its a hypothesis bias, and that's what I am tempted to attribute this one to. It seems financial slowdown's the reason why there's a spurt in the sale of anti-depressant drugs in the financial capital of India, Mumbai.
ET reports that Mumbai has recorded a 30% growth in the sale of anti-depressant medicines in the 12-month period ended August. This is much more than the 8% growth in the national market which is estimated at Rs 464 crore. Even in the month of August, when the sales of the anti-depressant segment dropped from Rs 41 crore in July to Rs 40 crore nationally, Mumbai was the only city which posted an 18% growth in sales of the drug. It grew from Rs 2.2 crore in July to Rs 2.6 crore in August.